Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0000899243-16-018581

Director disposed of 300,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Canaan IX L.P. Director 2016-04-25 Other disposition −300,000 4,584,755 I
Loading xslF345X03/doc4.xml…